Guyer William bought CORT
April 7, 2026 · Form 4 insider transaction
Guyer William bought 20,000 shares of Corcept Therapeutics Incorporated at $21.65 per share, a transaction worth $433.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$21.65
Total value
$433.0K
InsiderGuyer William
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 7, 2026
Filing dateApril 8, 2026
Shares owned after22,231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.